Cassava Sciences Valuation

SAVA Stock  USD 26.48  5.70  17.71%   
At this time, the firm appears to be undervalued. Cassava Sciences shows a prevailing Real Value of $43.84 per share. The current price of the firm is $26.48. Our model approximates the value of Cassava Sciences from analyzing the firm fundamentals such as Current Valuation of 1.15 B, return on equity of -0.11, and Shares Owned By Insiders of 13.37 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Cassava Sciences' valuation include:
Price Book
7.6451
Enterprise Value
1.2 B
Enterprise Value Ebitda
(8.26)
Forward PE
52.9101
Undervalued
Today
26.48
Please note that Cassava Sciences' price fluctuation is not too volatile at this time. Calculation of the real value of Cassava Sciences is based on 3 months time horizon. Increasing Cassava Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cassava Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cassava Stock. However, Cassava Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  26.48 Real  43.84 Target  99.5 Hype  26.45 Naive  28.5
The real value of Cassava Stock, also known as its intrinsic value, is the underlying worth of Cassava Sciences Company, which is reflected in its stock price. It is based on Cassava Sciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cassava Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
43.84
Real Value
49.63
Upside
Estimating the potential upside or downside of Cassava Sciences helps investors to forecast how Cassava stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cassava Sciences more accurately as focusing exclusively on Cassava Sciences' fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.31-0.31-0.31
Details
Hype
Prediction
LowEstimatedHigh
20.6626.4532.24
Details
Naive
Forecast
LowNext ValueHigh
22.7128.5034.29
Details
2 Analysts
Consensus
LowTarget PriceHigh
90.5599.50110.45
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cassava Sciences' intrinsic value based on its ongoing forecasts of Cassava Sciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cassava Sciences' closest peers. If more than one evaluation category is relevant for Cassava Sciences we suggest using both methods to arrive at a better estimate.

Cassava Sciences Cash

69.59 Million

Cassava Valuation Trend

Comparing Cassava Sciences' enterprise value against its market capitalization is a good way to estimate the value of Cassava Sciences uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.

Cassava Sciences Total Value Analysis

Cassava Sciences is at this time anticipated to have valuation of 1.15 B with market capitalization of 1.27 B, debt of 14.2 M, and cash on hands of 197.23 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cassava Sciences fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
1.15 B
1.27 B
14.2 M
197.23 M

Cassava Sciences Asset Utilization

One of the ways to look at asset utilization of Cassava is to check how much profit was generated for every dollar of assets it reports. Cassava Sciences shows a negative utilization of assets of -0.46 percent, losing $0.00456 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Cassava Sciences shows how discouraging it operates for each dollar spent on its assets.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Cassava Sciences Ownership Allocation

Cassava Sciences holds a total of 48.11 Million outstanding shares. Cassava Sciences shows significant amount of outstanding shares owned by insiders and institutional investors . Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Cassava Sciences Profitability Analysis

Net Loss for the year was (97.22 M) with loss before overhead, payroll, taxes, and interest of (68.03 M).
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cassava Sciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cassava Sciences and how it compares across the competition.

About Cassava Sciences Valuation

The stock valuation mechanism determines Cassava Sciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Cassava Sciences. We calculate exposure to Cassava Sciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cassava Sciences's related companies.
Last ReportedProjected for Next Year
Gross Profit-89.4 M-85 M
Pretax Profit Margin38.1 K40 K
Operating Profit Margin40 K42 K
Net Profit Margin36.2 K38 K
Gross Profit Margin 651.40  683.97 

Cassava Sciences Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding41.9 M
Forward Price Earnings52.9101

Cassava Sciences Current Valuation Indicators

Valuation refers to the process of determining the present value of Cassava Sciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Cassava we look at many different elements of the entity such as Cassava's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cassava Sciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cassava Sciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cassava Sciences' worth.

Complementary Tools for Cassava Stock analysis

When running Cassava Sciences' price analysis, check to measure Cassava Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cassava Sciences is operating at the current time. Most of Cassava Sciences' value examination focuses on studying past and present price action to predict the probability of Cassava Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cassava Sciences' price. Additionally, you may evaluate how the addition of Cassava Sciences to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume